表1_改善尼日利亚镰状细胞病患者获得医疗保健服务:医疗专业人员的观点和看法
尼日利亚镰状细胞病患者医疗服务可及性研究中医疗专业人员调查结果的Table 1文档,含问卷统计表格。

基本信息
资源简介
表1_改善尼日利亚镰状细胞病患者获得医疗保健服务:医疗专业人员的观点和看法
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集,收录 1 个文件、合计 24.13 KB,主题涵盖 sickle cell disease、haematology、genotype、public health、genetic,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Table 1_Improving access to healthcare services for sickle cell disease patients in Nigeria: perspectives and views of healthcare professionals.docx》。配套论文《Sickle cell disease is a global prototype for integrative research and healthcare》发表于 Advanced Genetics(2021),DOI:10.1002/ggn2.10037。源站首次发布:2025-08-25。
【数据内容】
源站原始描述:IntroductionIn sub-Saharan Africa, the burden of sickle cell disease remains high. With annual sickle cell births of about 150,000, Nigeria is reported to have the highest prevalence of the disease globally. This study aimed to explore the views and perspectives of healthcare professionals regarding access to healthcare services for sickle cell disease. MethodsA quantitative cross-sectional design was employed for this study. Participants comprised healthcare practitioners across Nigeria. A well…
【数据结构与技术规格】
文件数 1 个,合计 24.13 KB。Table 1_Improving access to healthcare services for sickle cell disease patients in Nigeria: perspectives and views of healthcare professionals.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,24.13 KB。数据集 DOI:10.3389/frhs.2025.1466299.s001。
【主题与分类】
源站学科分类:Public Health and Health Services not elsewhere classified。主题标签:sickle cell disease、haematology、genotype、public health、genetic、care。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://frontiersin.figshare.com/articles/dataset/Table_1_Improving_access_to_healthcare_services_for_sickle_cell_disease_patients_in_Nigeria_perspectives_and_views_of_healthcare_professionals_docx/29978023
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Onavbavba, Godspower; Adigwe, Obi Peter; Onoja, Solomon Oloche (2025). Table 1_Improving access to healthcare services for sickle cell disease patients in Nigeria: perspectives and views of healthcare professionals.docx. Frontiers. Dataset
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Table 1_Improving access to healthcare services for sickle cell disease patients in Nigeria: perspectives and views of healthcare professionals.docx
- DOI:10.3389/frhs.2025.1466299.s001
- 发布日期:2025-08-25
- 文件数:1 个
- 文件总体积:24.13 KB
- 源站页面:https://frontiersin.figshare.com/articles/dataset/Table_1_Improving_access_to_healthcare_services_for_sickle_cell_disease_patients_in_Nigeria_perspectives_and_views_of_healthcare_professionals_docx/29978023
命令行下载
curl -L -o "Table 1_Improving access to healthcare services for sickle cell disease patients in Nigeria: perspectives and views of healthcare professionals.docx" "https://ndownloader.figshare.com/files/57392449"
文件清单
Table 1_Improving access to healthcare services for sickle cell disease patients in Nigeria: perspectives and views of healthcare professionals.docx(24.13 KB)
文件总体积 24.13 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
IntroductionIn sub-Saharan Africa, the burden of sickle cell disease remains high. With annual sickle cell births of about 150,000, Nigeria is reported to have the highest prevalence of the disease globally. This study aimed to explore the views and perspectives of healthcare professionals regarding access to healthcare services for sickle cell disease.
MethodsA quantitative cross-sectional design was employed for this study. Participants comprised healthcare practitioners across Nigeria. A well-structured questionnaire was utilised for data collection. A stratified multistage sampling strategy was used for the study, and respondents were recruited from all the six geographical zones in the country. Data collected were entered into Statistical Package for Social Sciences (SPSS) software version 25. Descriptive and inferential statistical analyses were undertaken. Results were presented in frequencies and percentages.
ResultsThe response rate was 83.5% (1,002/1,200); male and female participants were of similar proportions, as indicated by 51.2% and 48.8%, respectively. A significant proportion of the participants (43.1%) disagreed that development partners have adequately contributed to the funding of sickle cell disease research in Nigeria. The majority of the respondents (81%) indicated that providing special funding for health research can facilitate access to healthcare services for sickle cell patients, whilst a similar proportion (79.2%) disagreed that the government alone bears the responsibility for healthcare initiatives for the disease. A third of the study participants (67.8%) were of the view that current research and development efforts towards sickle cell disease were inadequate.
ConclusionThis study describes health professionals’’ views on access to healthcare for sickle cell, and the findings revealed the criticality of private and development sector funding in reducing the burden of the disease. Furthermore, capacity building at the primary healthcare level would not only ensure access to the basic healthcare needs of patients but could also demystify the condition.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.3389/frhs.2025.1466299.s001(source: https://frontiersin.figshare.com/articles/dataset/Table_1_Improving_access_to_healthcare_services_for_sickle_cell_disease_patients_in_Nigeria_perspectives_and_views_of_healthcare_professionals_docx/29978023)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




